Suzhou Basecare Medical Corporation Limited (2170.HK)
HKD 3.11
(-2.81%)
HKD 3.11
(-2.81%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -661.29 Million CNY | 47.37% |
| 2022 | -1.25 Billion CNY | 14.78% |
| 2021 | -1.47 Billion CNY | -816.76% |
| 2020 | -160.85 Million CNY | -2002.9% |
| 2019 | 8.45 Million CNY | 47.75% |
| 2018 | 5.72 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -436.49 Million CNY | 2.23% |
| 2024 Q1 | -436.49 Million CNY | 33.99% |
| 2023 Q4 | -661.29 Million CNY | 0.7% |
| 2023 FY | -661.29 Million CNY | 47.37% |
| 2023 Q3 | -665.98 Million CNY | 23.55% |
| 2023 Q2 | -871.12 Million CNY | 0.42% |
| 2023 Q1 | -874.8 Million CNY | 30.38% |
| 2022 Q3 | -1.25 Billion CNY | 2.13% |
| 2022 Q2 | -1.28 Billion CNY | 0.28% |
| 2022 Q1 | -1.28 Billion CNY | 12.53% |
| 2022 FY | -1.25 Billion CNY | 14.78% |
| 2022 Q4 | -1.25 Billion CNY | 0.17% |
| 2021 FY | -1.47 Billion CNY | -816.76% |
| 2021 Q1 | -1.66 Billion CNY | -934.8% |
| 2021 Q4 | -1.47 Billion CNY | 0.21% |
| 2021 Q3 | -1.47 Billion CNY | 11.09% |
| 2021 Q2 | -1.66 Billion CNY | 0.15% |
| 2020 Q3 | -193.5 Million CNY | -5719.73% |
| 2020 Q2 | -3.32 Million CNY | 0.0% |
| 2020 Q1 | -3.32 Million CNY | -139.34% |
| 2020 Q4 | -160.85 Million CNY | 16.87% |
| 2020 FY | -160.85 Million CNY | -2002.9% |
| 2019 Q4 | 8.45 Million CNY | 0.0% |
| 2019 FY | 8.45 Million CNY | 47.75% |
| 2019 Q1 | 70.05 Million CNY | 0.0% |
| 2018 FY | 5.72 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Vincent Medical Holdings Limited | -138.39 Million HKD | -377.821% |